Coya Therapeutics Inc. (NASDAQ: COYA)
$5.2500
+0.0100 ( 0% ) 7.1K
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
Market Data
Open
$5.2500
Previous close
$5.2400
Volume
7.1K
Market cap
$92.56M
Day range
$5.3900 - $5.6890
52 week range
$4.7500 - $10.6899
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 12 | May 09, 2024 |
| 10-q | Quarterly Reports | 51 | May 09, 2024 |
| 8-k | 8K-related | 14 | May 08, 2024 |
| ars | Annual reports | 1 | Mar 28, 2024 |
| def | Proxies and info statements | 2 | Mar 28, 2024 |
| 8-k | 8K-related | 12 | Mar 19, 2024 |
| 10-k | Annual reports | 95 | Mar 19, 2024 |
| 4 | Insider transactions | 1 | Mar 05, 2024 |
| 4 | Insider transactions | 1 | Feb 02, 2024 |
| 4 | Insider transactions | 1 | Feb 02, 2024 |